BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 9801167)

  • 1. Interactions between synthetic vanilloids and the endogenous cannabinoid system.
    Di Marzo V; Bisogno T; Melck D; Ross R; Brockie H; Stevenson L; Pertwee R; De Petrocellis L
    FEBS Lett; 1998 Oct; 436(3):449-54. PubMed ID: 9801167
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Unsaturated long-chain N-acyl-vanillyl-amides (N-AVAMs): vanilloid receptor ligands that inhibit anandamide-facilitated transport and bind to CB1 cannabinoid receptors.
    Melck D; Bisogno T; De Petrocellis L; Chuang H; Julius D; Bifulco M; Di Marzo V
    Biochem Biophys Res Commun; 1999 Aug; 262(1):275-84. PubMed ID: 10448105
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anandamide transport inhibition by the vanilloid agonist olvanil.
    Beltramo M; Piomelli D
    Eur J Pharmacol; 1999 Jan; 364(1):75-8. PubMed ID: 9920187
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular targets for cannabidiol and its synthetic analogues: effect on vanilloid VR1 receptors and on the cellular uptake and enzymatic hydrolysis of anandamide.
    Bisogno T; Hanus L; De Petrocellis L; Tchilibon S; Ponde DE; Brandi I; Moriello AS; Davis JB; Mechoulam R; Di Marzo V
    Br J Pharmacol; 2001 Oct; 134(4):845-52. PubMed ID: 11606325
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of palmitoylethanolamide transport in mouse Neuro-2a neuroblastoma and rat RBL-2H3 basophilic leukaemia cells: comparison with anandamide.
    Jacobsson SO; Fowler CJ
    Br J Pharmacol; 2001 Apr; 132(8):1743-54. PubMed ID: 11309246
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Arachidonoylserotonin and other novel inhibitors of fatty acid amide hydrolase.
    Bisogno T; Melck D; De Petrocellis L; Bobrov MYu ; Gretskaya NM; Bezuglov VV; Sitachitta N; Gerwick WH; Di Marzo V
    Biochem Biophys Res Commun; 1998 Jul; 248(3):515-22. PubMed ID: 9703957
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The uptake by cells of 2-arachidonoylglycerol, an endogenous agonist of cannabinoid receptors.
    Bisogno T; MacCarrone M; De Petrocellis L; Jarrahian A; Finazzi-Agrò A; Hillard C; Di Marzo V
    Eur J Biochem; 2001 Apr; 268(7):1982-9. PubMed ID: 11277920
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of rat C6 glioma cell proliferation by endogenous and synthetic cannabinoids. Relative involvement of cannabinoid and vanilloid receptors.
    Jacobsson SO; Wallin T; Fowler CJ
    J Pharmacol Exp Ther; 2001 Dec; 299(3):951-9. PubMed ID: 11714882
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The novel endogenous cannabinoid 2-arachidonoylglycerol is inactivated by neuronal- and basophil-like cells: connections with anandamide.
    Di Marzo V; Bisogno T; Sugiura T; Melck D; De Petrocellis L
    Biochem J; 1998 Apr; 331 ( Pt 1)(Pt 1):15-9. PubMed ID: 9512456
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overlap between the ligand recognition properties of the anandamide transporter and the VR1 vanilloid receptor: inhibitors of anandamide uptake with negligible capsaicin-like activity.
    De Petrocellis L; Bisogno T; Davis JB; Pertwee RG; Di Marzo V
    FEBS Lett; 2000 Oct; 483(1):52-6. PubMed ID: 11033355
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modulation of trigeminal sensory neuron activity by the dual cannabinoid-vanilloid agonists anandamide, N-arachidonoyl-dopamine and arachidonyl-2-chloroethylamide.
    Price TJ; Patwardhan A; Akopian AN; Hargreaves KM; Flores CM
    Br J Pharmacol; 2004 Apr; 141(7):1118-30. PubMed ID: 15006899
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Palmitoylethanolamide inhibits the expression of fatty acid amide hydrolase and enhances the anti-proliferative effect of anandamide in human breast cancer cells.
    Di Marzo V; Melck D; Orlando P; Bisogno T; Zagoory O; Bifulco M; Vogel Z; De Petrocellis L
    Biochem J; 2001 Aug; 358(Pt 1):249-55. PubMed ID: 11485574
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect on cancer cell proliferation of palmitoylethanolamide, a fatty acid amide interacting with both the cannabinoid and vanilloid signalling systems.
    De Petrocellis L; Bisogno T; Ligresti A; Bifulco M; Melck D; Di Marzo V
    Fundam Clin Pharmacol; 2002 Aug; 16(4):297-302. PubMed ID: 12570018
    [TBL] [Abstract][Full Text] [Related]  

  • 14. N-acyl-dopamines: novel synthetic CB(1) cannabinoid-receptor ligands and inhibitors of anandamide inactivation with cannabimimetic activity in vitro and in vivo.
    Bisogno T; Melck D; Bobrov MYu ; Gretskaya NM; Bezuglov VV; De Petrocellis L; Di Marzo V
    Biochem J; 2000 Nov; 351 Pt 3(Pt 3):817-24. PubMed ID: 11042139
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cannabinoid activation of recombinant and endogenous vanilloid receptors.
    Ralevic V; Kendall DA; Jerman JC; Middlemiss DN; Smart D
    Eur J Pharmacol; 2001 Jul; 424(3):211-9. PubMed ID: 11672565
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel selective and metabolically stable inhibitors of anandamide cellular uptake.
    Ortar G; Ligresti A; De Petrocellis L; Morera E; Di Marzo V
    Biochem Pharmacol; 2003 May; 65(9):1473-81. PubMed ID: 12732359
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuroprotection by the endogenous cannabinoid anandamide and arvanil against in vivo excitotoxicity in the rat: role of vanilloid receptors and lipoxygenases.
    Veldhuis WB; van der Stelt M; Wadman MW; van Zadelhoff G; Maccarrone M; Fezza F; Veldink GA; Vliegenthart JF; Bär PR; Nicolay K; Di Marzo V
    J Neurosci; 2003 May; 23(10):4127-33. PubMed ID: 12764100
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of homologues and analogues of palmitoylethanolamide upon the inactivation of the endocannabinoid anandamide.
    Jonsson KO; Vandevoorde S; Lambert DM; Tiger G; Fowler CJ
    Br J Pharmacol; 2001 Aug; 133(8):1263-75. PubMed ID: 11498512
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypolocomotor effects in rats of capsaicin and two long chain capsaicin homologues.
    Di Marzo V; Lastres-Becker I; Bisogno T; De Petrocellis L; Milone A; Davis JB; Fernandez-Ruiz JJ
    Eur J Pharmacol; 2001 May; 420(2-3):123-31. PubMed ID: 11408034
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of topical anandamide-transport inhibitors, AM404 and olvanil, on intraocular pressure in normotensive rabbits.
    Laine K; Järvinen T; Savinainen J; Laitinen JT; Pate DW; Järvinen K
    Pharm Res; 2001 Apr; 18(4):494-9. PubMed ID: 11451037
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.